⌘K

Login Start Free

Home/Filings/4/0001334549-24-000004

4//SEC Filing

Mazzo David J 4

Accession 0001334549-24-000004

CIK 0000320017other

View on SEC.gov Company Profile

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 4:02 PM ET

Size

5.1 KB

Accession

0001334549-24-000004

Insider Transaction Report

Form 4

Period: 2024-01-11

LISATA THERAPEUTICS, INC.LSTA

DirectorPresident & CEO

Transactions

Tax Payment
Common Stock
2024-01-11$2.99/sh−1,026$3,068→ 174,766 total

Footnotes (2)

[F1]Shares withheld as payment of a tax liability on vesting of restricted stock.
[F2]Includes 107,183 unvested restricted stock.

Documents

1 file

4
wk-form4_1705093334.xmlPrimary
FORM 4

Issuer

LISATA THERAPEUTICS, INC.

CIK 0000320017

Entity typeother

Related Parties

1

filerCIK 0001334549

Filing Metadata

Form type: 4
Filed: Jan 11, 7:00 PM ET
Accepted: Jan 12, 4:02 PM ET
Size: 5.1 KB

View on SEC.gov